logo-loader
CSE:XPHY OTCQB:XPHYF

XPhyto Therapeutics Corp.

Receive alerts
Market:
CSE
Price
-
Day Change
-
Market Cap:
-
52 weeks high
-
52 weeks low
-

In brief

XPhyto Therapeutics Corp is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities. This includes precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. The firm has R&D operations in North America and Europe, with an operational focus in Germany. It is currently focused on regulatory approval and commercialization of medical products for European markets.